| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |